Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-12-26

Clinical Trial Update: Telavancin Blood and Cerebrospinal Fluid Concentrations in Patients With External Ventricular Drainage [Phase 4]

View source ↗

Summary

This Phase 4 clinical trial update assesses the concentrations of telavancin in blood and cerebrospinal fluid in patients with external ventricular drainage aft…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Telavancin (telavancin)

Snippet

Sponsor: Aaron Cook | Conditions: Subarachnoid Hemorrhage, Aneurysmal | Phase 4 | Status: RECRUITING